Antigen bias in T cell cross-priming

Science

Volumn 304, Issue 5675, 2004, Pages 1314-1317

  Wolkers, Monika C ^a   Brouwenstijn, Nathalie ^a   Bakker, Arnold H ^a   Toebes, Mireille ^a   Schumacher, Ton N M ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; COMPLEXATION; DEGRADATION; PROTEINS; TUMORS; VIRUSES;

CROSS-PRIMING; HISTOCOMPATIBILITY;

ANTIGENS;

ANTIGEN; CD8 ANTIGEN; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; TUMOR ANTIGEN; VACCINE; VIRUS ANTIGEN;

ANTIGEN; IMMUNE SYSTEM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; DRUG DESIGN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; T LYMPHOCYTE ACTIVATION; TUMOR CELL; VIRUS INFECTION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CROSS-PRIMING; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; IMMUNE TOLERANCE; IMMUNOGLOBULINS; INFLUENZA A VIRUS; LYMPHOCYTE ACTIVATION; MICE; PAPILLOMAVIRIDAE; PROTEIN SORTING SIGNALS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; VACCINES;

ANIMALIA;

EID: 2542616960     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1096268     Document Type: Article

References (29)

1. A. F. Ochsenbein et al., Proc. Natl. Acad. Sci. U.S.A. 96, 2233 (1999).
2. M. J. Bevan, J. Exp. Med. 143, 1283 (1976).
3. A. Y. Huang et al., Science 264, 961 (1994).
4. L. J. Sigal, S. Crotty, R. Andino, K. L. Rock, Nature 398, 77 (1999).
5. M. C. Wolkers, G. Stoetter, F. A. Vyth-Dreese, T. N. Schumacher, J. Immunol. 167, 3577 (2001).
6. A. F. Ochsenbein et al., Nature 411, 1058 (2001).
7. R. M. Zinkernagel, Eur. J. Immunol. 32, 2385 (2002).
8. See supporting data on Science Online.
9. J. Hombach, H. Pircher, S. Tonegawa, R. M. Zinkernagel, J. Exp. Med. 182, 1615 (1995).
10. W. Chen, H. Qin, B. Chesebro, M. A. Cheever, J. Virol. 70, 7773 (1996).
11. T. Wolfel et al., Eur. J. Immunol. 24, 759 (1994).
12. B. Martoglio, B. Dobberstein, Trends Cell Biol. 8, 410 (1998).
13. J. L. McCoy, A. Fefer, J. P. Glynn, Cancer Res. 27, 1743 (1967).
14. M. C. Wolkers, A. H. Bakker, T. N. Schumacher, unpublished data.
15. I. Bacik, J. H. Cox, R. Anderson, J. W. Yewdell, J. R. Bennink, J. Immunol. 152, 381 (1994).
16. G. T. Belz, P. G. Stevenson, P. C. Doherty, J. Immunol. 165, 2404 (2000).
17. A. Rodriguez, A. Regnault, M. Kleijmeer, P. Ricciardi-Castagnoli, S. Amigorena, Nature Cell Biol. 1, 362 (1999).
18. J. M. den Haan, M. J. Bevan, J. Exp. Med. 196, 817 (2002).
19. D. Kitamura, J. Roes, R. Kuhn, K. Rajewsky, Nature 350, 423 (1991).
20. C. Winzler et al., J. Exp. Med. 185, 317 (1997).
21. P. S. Ohashi et al., Cell 65, 305 (1991).
22. R. M. Steinman, M. C. Nussenzweig, Proc. Natl. Acad. Sci. U.S.A. 99, 351 (2002).
23. D. E. Speiser et al., J. Exp. Med. 186, 645 (1997).
24. L. Shen, K. L. Rock, Proc. Natl. Acad. Sci. U.S.A. 101, 3035 (2004).
25. C. C. Norbury et al., Science 304, 1318 (2004).
26. J. W. Yewdell E. Reits, J. Neefjes, Nature Rev. Immunol. 3, 952 (2003).
27. J. D. Altman et al., Science 274, 94 (1996).
28. J. B. Haanen et al., Eur. J. Immunol. 29, 1168 (1999).
29. We thank E. Swart for technical assistance, A. Pfauth and F. van Diepen for flow cytometry assistance, R. Offringa for mouse embryonic cells, P. Ricciardi-Castagnoli for the D1 cells, and J. Neefjes for antibody to GFP. Supported by Netherlands Organization of Scientific Research grant NWO 901-07-233 (N.B.) and by Dutch Cancer Society grants NKI 99-2036 and NKI 2001-2563.